These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3110896)

  • 41. Hypercalcaemic osteomalacia due to aluminium toxicity.
    Boyce BF; Fell GS; Elder HY; Junor BJ; Elliot HL; Beastall G; Fogelman I; Boyle IT
    Lancet; 1982 Nov; 2(8306):1009-13. PubMed ID: 6127501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Persisting aluminium-related bone disease after cadaveric renal transplantation.
    Nicholas JC; Dawes PT; Davies SJ; Freemont AJ
    Nephrol Dial Transplant; 1999 Jan; 14(1):202-4. PubMed ID: 10052510
    [No Abstract]   [Full Text] [Related]  

  • 43. The case for parathyroid hormone.
    Mayor GH
    Am J Kidney Dis; 1985 Nov; 6(5):306-8. PubMed ID: 3904422
    [No Abstract]   [Full Text] [Related]  

  • 44. Aluminum-associated bone disease: considerations on the pathogenesis and the effects of deferoxamine treatment.
    Kurokawa K; Marumo F; Ogura Y; Ono T; Suzuki M
    J UOEH; 1987 Mar; 9 Suppl():133-9. PubMed ID: 3602744
    [No Abstract]   [Full Text] [Related]  

  • 45. The localization of aluminum in bone: implications for the mechanism of fixation and for the pathogenesis of aluminum-related bone disease.
    Parfitt AM
    Int J Artif Organs; 1988 Mar; 11(2):79-90. PubMed ID: 3286529
    [No Abstract]   [Full Text] [Related]  

  • 46. Aluminum, parathyroid hormone, and osteomalacia.
    Burnatowska-Hledin MA; Kaiser L; Mayor GH
    Spec Top Endocrinol Metab; 1983; 5():201-26. PubMed ID: 6422572
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aluminum bone disease. (A case study).
    Coleman S
    J Nephrol Nurs; 1985; 2(3):125-6. PubMed ID: 3848476
    [No Abstract]   [Full Text] [Related]  

  • 48. [Bone and aluminum].
    Wendling D; Guidet M
    Rev Rhum Mal Osteoartic; 1986 Dec; 53(12):705-13. PubMed ID: 3103201
    [No Abstract]   [Full Text] [Related]  

  • 49. Sporadic aluminum osteomalacia: identification of patients at risk.
    Turner MW; Ardila M; Hutchinson T; Prichard S; Barré PE; Beauvais J; Kaye M
    Am J Kidney Dis; 1988 Jan; 11(1):51-6. PubMed ID: 3337100
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Toxic effect of aluminum in chronic renal failure].
    Głuszek J
    Pol Tyg Lek; 1987 Nov; 42(48):1499-502. PubMed ID: 3451199
    [No Abstract]   [Full Text] [Related]  

  • 51. Deferoxamine therapy of bone aluminum accumulation in renal dialysis patients.
    Nutr Rev; 1985 Apr; 43(4):103-5. PubMed ID: 3923410
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of dialysis osteomalacia with desferrioxamine.
    Brown DJ; Dawborn JK; Ham KN; Xipell JM
    Lancet; 1982 Aug; 2(8294):343-5. PubMed ID: 6124756
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The case against aluminum affecting parathyroid function.
    Alfrey AC
    Am J Kidney Dis; 1985 Nov; 6(5):309-12. PubMed ID: 4061453
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Chronic aluminum intoxication in patients with terminal kidney failure on programmed hemodialysis (literature review)].
    Milovanova LIu; Nikolaev AIu; Barashkov GK
    Ter Arkh; 2001; 73(6):67-9. PubMed ID: 11521528
    [No Abstract]   [Full Text] [Related]  

  • 55. Aluminum-induced dialysis osteodystrophy: the demise of "Newcastle bone disease"?
    Kerr DN; Ward MK; Arze RS; Ramos JM; Grekas D; Parkinson IS; Ellis HA; Owen JP; Simpson W; Dewar J
    Kidney Int Suppl; 1986 Feb; 18():S58-64. PubMed ID: 3457998
    [No Abstract]   [Full Text] [Related]  

  • 56. Improvement of anemia with deferoxamine in hemodialysis patients with aluminum-induced bone disease.
    Tielemans C; Collart F; Wens R; Smeyers-Verbeeke J; van Hooff I; Dratwa M; Verbeelen D
    Clin Nephrol; 1985 Nov; 24(5):237-41. PubMed ID: 4075595
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of fracturing renal osteodystrophy by desferrioxamine.
    Ackrill P; Day JP; Garstang FM; Hodge KC; Metcalfe PJ; Benzo Z; Hill K; Ralston AJ; Ball J; Denton J
    Proc Eur Dial Transplant Assoc; 1983; 19():203-7. PubMed ID: 6878234
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment and histological healing of aluminum-related osteomalacia.
    Boyce BF; Mocan MZ; Byars J; Junor BJ
    Contrib Nephrol; 1988; 64():151-9. PubMed ID: 3180822
    [No Abstract]   [Full Text] [Related]  

  • 59. Role of plasma aluminum in the detection and prevention of aluminum toxicity.
    Winney RJ; Cowie JF; Robson JS
    Kidney Int Suppl; 1986 Feb; 18():S91-5. PubMed ID: 3458005
    [No Abstract]   [Full Text] [Related]  

  • 60. The efficacy of various treatment modalities on aluminium associated bone disease.
    Ihle BU; Buchanan MR; Stevens B; Becker GJ; Kincaid-Smith P
    Proc Eur Dial Transplant Assoc; 1983; 19():195-202. PubMed ID: 6348735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.